XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statement of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Common stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2020 $ 116,399 $ 15 $ 190,568 $ (74,773) $ 589
Beginning Balance, shares at Dec. 31, 2020   15,476,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 8,838     8,838  
Other comprehensive loss, net of tax (711)       (711)
Issuance of restricted stock 113   113    
Issuance of restricted stock, shares   26,000      
Stock options exercised 912 $ 1 911    
Stock options exercised, shares   159,000      
Stock-based compensation 1,786   1,786    
Repurchase of common stock and retirement of related treasury shares (215)   (215)    
Repurchase of common stock and retirement of related treasury shares, shares   (6,000)      
Ending Balance at Mar. 31, 2021 127,122 $ 16 193,163 (65,935) (122)
Ending Balance, shares at Mar. 31, 2021   15,655,000      
Beginning Balance at Dec. 31, 2021 141,369 $ 16 198,278 (57,052) 127
Beginning Balance, shares at Dec. 31, 2021   16,168,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (6,476)     (6,476)  
Other comprehensive loss, net of tax (429)       (429)
Issuance of restricted stock, shares   30,000      
Stock options exercised $ 361   361    
Stock options exercised, shares 47,078 47,000      
Stock-based compensation $ 1,537   1,537    
Ending Balance at Mar. 31, 2022 $ 136,362 $ 16 $ 200,176 $ (63,528) $ (302)
Ending Balance, shares at Mar. 31, 2022   16,245,000